The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Pfizer naming David Cullinane .

Filed returns
15
match these filters
Matching filed returns per period 0 0 1 1 2 Jan–Apr 2018: 1 filed returns Jan–Apr 2021: 2 filed returns May–Aug 2021: 2 filed returns Sep–Dec 2021: 1 filed returns Jan–Apr 2022: 1 filed returns May–Aug 2022: 2 filed returns Jan–Apr 2024: 1 filed returns Sep–Dec 2024: 2 filed returns Jan–Apr 2025: 2 filed returns Sep–Dec 2025: 1 filed returns 2018 2021 2022 2024 2025
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2025 Pfizer Health Expansion of the National Immunisation Programme to include RSV vaccination for older adults (Public policy or programme) 19 On lobbying.ie
Jan–Apr 2025 Pfizer Health Expansion of the National Immunisation Programme to include RSV protection for infants and older adults (Public policy or programme) 6 On lobbying.ie
Jan–Apr 2025 Pfizer Health Ireland's medicine reimbursement system and funding for access to new medicines and vaccines (Matters involving public funds) 7 On lobbying.ie
Sep–Dec 2024 Pfizer Health Access to an antiviral medication for the treatment of COVID-19 (Matters involving public funds) 5 On lobbying.ie
Sep–Dec 2024 Pfizer Health Ireland's medicine reimbursement system and funding for access to new medicines and vaccines (Matters involving public funds) 15 On lobbying.ie
Jan–Apr 2024 Pfizer Health Ireland's medicine reimbursement system and access to new medicines and vaccines (Matters involving public funds) 14 On lobbying.ie
May–Aug 2022 Pfizer Economic Development and Industry COVID-19 Trips waiver - vaccines and therapeutics (Public policy or programme) 17 On lobbying.ie
May–Aug 2022 Pfizer Health Pfizer COVID-19 anti-viral treatment (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2022 Pfizer Economic Development and Industry Proposed COVID-19 Trips waiver (Public policy or programme) 12 On lobbying.ie
Sep–Dec 2021 Pfizer Health Pfizer has an investigational COVID-19 treatment, a protease inhibitor which subject to clinical trials and regulatory approvals could play a complementary role to vaccination in helping to manage COVID-19 (Matters involving public funds) 5 On lobbying.ie
May–Aug 2021 Pfizer Health Supply of Pfizer COVID-19 vaccine including Ireland volumes; expansion of manufacturing capacity to include Grange Castle site and Pfizer colleague vaccination programme (Public policy or programme) 8 On lobbying.ie
May–Aug 2021 Pfizer Health Outline Ireland's medicine reimbursement system and timelines compared with other countries (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2021 Pfizer Health Highlight Ireland's slowness in reimbursing new medicines for Irish patients compared with other EU countries (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2021 Pfizer Health Updates in relation to Pfizer COVID 19 vaccine including global production, Ireland volumes and company colleague vaccination programme (Matters involving public funds) 10 On lobbying.ie
Jan–Apr 2018 Pfizer Taxation Global competition for FDI and life sciences investment continues to intensify and Ireland continues to compete for such investment. Pfizer has extensive operations in Ireland where many of Pfizer's leading and newest… (Public policy or programme) 21 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 12 80.0%
Economic Development and Industry 2 13.3%
Taxation 1 6.7%